According to the pathophysiology described above, it is thought that MG53 acts as a ubiquitin E3 ligase and mediates the degradation of IRS-1, resulting in systemic insulin resistance and ultimately metabolic syndrome [25]. Here, IRS1 is linked to Insulin resistance.